Share
CNBC Investing Club

Jim Cramer gives his take on Boise Cascade and ChemoCentryx

The "Mad Money" host explained his thoughts on Boise Cascade and ChemoCentryx, and whether investors should buy shares of the companies, on Monday's episode of the show.
08:41
Mon, Aug 15 20227:12 PM EDT